FibroGen Europe
Headquartered in Helsinki, Finland, FibroGen Europe is a biotechnology company focused on the development and commercialization of recombinant collagens and gelatins in Europe. The Company's expertise in extracellular matrix technology, coupled with its substantial intellectual property position, allows FibroGen Europe to assume a leadership position in the European recombinant collagen and gelatin marketplaces. FibroGen Europe will focus its efforts on supplying its novel biomaterials to European companies in the medical device and pharmaceutical industries, as well as commercializing products of its own design. FibroGen Europe is a majority owned subsidiary of FibroGen, Inc., San Francisco, California.
|
Address: |
Company Brochure: PDF format, 374KB
|
|---|
|
Worldwide Collagen Team: FibroGen's recombinant collagen and gelatin programs are coordinated through its headquarters in San Francisco, California and at FibroGen Europe in Helsinki, Finland. |
  |
